RLAY

Relay Therapeutics, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$18.08

Price (1 Year)

$20 $7.35

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0 / %30
Non-compliant assets / Total market cap %59.6 / %30
Non-compliant revenue / Total income %86.2 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications.

Website

Analysis (Turkish): RLAY Hissesi Caiz mi, Helal mi? Relay Therapeutics, Inc. Katılım Analizi